Bruce Booth - 14 Mar 2024 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Reporting relationship: Director
Issuer ticker: KYMR
Reported as of: 14 Mar 2024
Net transaction value: -$5,133,263
SEC form: 4
Accepted by SEC: 15 Mar 2024, 19:23:41 UTC
Prior SEC filing: 13 Mar 2024
Next SEC filing: 07 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Ommer Chohan, Attorney-in-Fact

Key filing fact

Bruce Booth filed Form 4 for Kymera Therapeutics, Inc. (KYMR) on 15 Mar 2024.

Key facts

This page summarizes Bruce Booth's Form 4 filing for Kymera Therapeutics, Inc. (KYMR).
12 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Mar 2024, 19:23.

Change

Previous filing in this sequence was filed on 13 Mar 2024.
Current net transaction value: -$5,133,263.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KYMR transaction

Common Stock

Sale

Transaction value: $1,369,612
Shares: -34,473
Change %: -0.74%
Price: $39.73
Shares after: 4,641,602
Date: 14 Mar 2024
Ownership: See footnote
Footnotes: F1, F2, F3

KYMR transaction

Common Stock

Sale

Transaction value: $440,998
Shares: -10,846
Change %: -0.23%
Price: $40.66
Shares after: 4,630,756
Date: 14 Mar 2024
Ownership: See footnote
Footnotes: F1, F3, F4

KYMR transaction

Common Stock

Sale

Transaction value: $32,419
Shares: -781
Change %: -0.02%
Price: $41.51
Shares after: 4,629,975
Date: 14 Mar 2024
Ownership: See footnote
Footnotes: F1, F3, F5

KYMR transaction

Common Stock

Sale

Transaction value: $289,711
Shares: -7,292
Change %: -0.88%
Price: $39.73
Shares after: 821,538
Date: 14 Mar 2024
Ownership: See footnote
Footnotes: F2, F6, F7

KYMR transaction

Common Stock

Sale

Transaction value: $90,794
Shares: -2,233
Change %: -0.27%
Price: $40.66
Shares after: 819,305
Date: 14 Mar 2024
Ownership: See footnote
Footnotes: F4, F6, F7

KYMR transaction

Common stock

Sale

Transaction value: $6,393
Shares: -154
Change %: -0.02%
Price: $41.51
Shares after: 819,151
Date: 14 Mar 2024
Ownership: See footnote
Footnotes: F5, F6, F7

KYMR transaction

Common Stock

Sale

Transaction value: $319,433
Shares: -8,126
Change %: -0.18%
Price: $39.31
Shares after: 4,621,849
Date: 15 Mar 2024
Ownership: See footnote
Footnotes: F1, F3, F8

KYMR transaction

Common Stock

Sale

Transaction value: $2,014,386
Shares: -49,591
Change %: -1.1%
Price: $40.62
Shares after: 4,572,258
Date: 15 Mar 2024
Ownership: See footnote
Footnotes: F1, F3, F9

KYMR transaction

Common Stock

Sale

Transaction value: $65,679
Shares: -1,593
Change %: -0.03%
Price: $41.23
Shares after: 4,570,665
Date: 15 Mar 2024
Ownership: See footnote
Footnotes: F1, F3, F10

KYMR transaction

Common Stock

Sale

Transaction value: $67,377
Shares: -1,714
Change %: -0.21%
Price: $39.31
Shares after: 817,437
Date: 15 Mar 2024
Ownership: See footnote
Footnotes: F6, F7, F8

KYMR transaction

Common Stock

Sale

Transaction value: $422,895
Shares: -10,411
Change %: -1.3%
Price: $40.62
Shares after: 807,026
Date: 15 Mar 2024
Ownership: See footnote
Footnotes: F6, F7, F9

KYMR transaction

Common Stock

Sale

Transaction value: $13,565
Shares: -329
Change %: -0.04%
Price: $41.23
Shares after: 806,697
Date: 15 Mar 2024
Ownership: See footnote
Footnotes: F6, F7, F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. on January 22, 2024.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.2558 to $40.2537 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (8), (9) and (10).

Footnote F3

These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extend of his pecuniary interest therein, if any.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.26 to $41.2563 inclusive.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.2712 to $41.7267 inclusive.

Footnote F6

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Opportunity Fund I, L.P. on January 22, 2024.

Footnote F7

The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVOF I. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF I, except to the extent of his pecuniary interest therein, if any.

Footnote F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.13 to $40.1296 inclusive.

Footnote F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.1375 to $41.13 inclusive.

Footnote F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.1413 to $41.43 inclusive.